FIP Statement of policy: Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution

H Sasaki, LA Sheikh, A Vulto, A Bennett, Ross McKinnon, W Jama, M Andersson, M Ghalyini, D Van Broeck, R Yagudina, SG Chang, JM Oh, Z Kusynova

Research output: Book/Report › Commissioned report › peer-review

Abstract

The purpose of this document is to provide a set of recommendations on therapeutic interchange and substitution of pharmaceutical products, including with biosimilars.
Original languageEnglish
Place of PublicationThe Hague, Netherlands
PublisherInternational Pharmaceutical Federation
Number of pages7
Publication statusPublished - 2 Sep 2018

Keywords

  • Policy statement
  • pharmaceutical selection
  • Drug selection
  • interchange
  • substitution
  • pharmacist

Access to Document

Fingerprint Dive into the research topics of 'FIP Statement of policy: Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution'. Together they form a unique fingerprint.

Cite this